You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Linagliptin

Showing 26 - 50 of 210
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes, Coronary Artery Disease Trial in Graz (Linagliptin, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Coronary Artery Disease
  • Linagliptin
  • Placebo
  • Graz, Austria
    Medical University of Graz, Department for Internal Medicine
May 14, 2020

Healthy Trial in Biberach (High dose FDC Empagliflozin/Linagliptin/Metformin XR, fed, 1 tab Empagliflozin +1 tab Linagliptin +2

Completed
Has Results
  • Healthy
  • High dose FDC Empagliflozin/Linagliptin/Metformin XR, fed
  • +3 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Feb 25, 2020

Healthy Trial in Biberach (Empagliflozin/linagliptin/metformin HCl, Empagliflozin, Linagliptin)

Completed
Has Results
  • Healthy
  • Empagliflozin/linagliptin/metformin HCl
  • +3 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Feb 25, 2020

Hypertension, Diabetes Trial in Seoul (Treatment A (Fimasartan, Linagliptin), Treatment B (Fimasartan/Linagliptin))

Completed
  • Hypertension
  • Diabetes
  • Treatment A (Fimasartan, Linagliptin)
  • Treatment B (Fimasartan/Linagliptin)
  • Seoul, Dahak-ro, Korea, Republic of
    Seoul National University Hospital
Feb 3, 2020

Impaired Glucose Tolerance, Insulin Sensitivity, Glucose Metabolism Disorders Trial in Oslo (Metformin capsule 500 mg,

Recruiting
  • Impaired Glucose Tolerance
  • +2 more
  • Metformin capsule 500 mg, Empagliflozin encapsulated tablet 10 mg, Pioglitazone encapsulated tablet 30 mg, Linagliptin encapsulated tablet 5 mg
  • Oslo, Norway
    Oslo University Hospital, Aker Hospital
Apr 5, 2021

Type 2 Diabetes Trial in Guangzhou (CSII followed by Lina+MET, CSII followed by Lina, CSII followed by MET)

Recruiting
  • Type 2 Diabetes Mellitus
  • CSII followed by Lina+MET
  • +3 more
  • Guangzhou, Guangdong, China
    endocrinology department of the first affiliated hospital of Sun
Apr 28, 2021

Healthy Trial in Biberach (Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination), Empagliflozin, Linagliptin)

Completed
Has Results
  • Healthy
  • Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination)
  • +3 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Feb 6, 2020

Diabetes, Type 2 Trial in Beijing, Baotou (HSK7653 10 mg Q2W, HSK7653 25 mg Q2W, Linagliptin 5 mg QD)

Recruiting
  • Diabetes Mellitus, Type 2
  • HSK7653 10 mg Q2W
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Nov 19, 2020

Research Program for Assessment of Safety and Effectiveness of

Completed
Has Results
  • Diabetes Mellitus, Type 2
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Mar 19, 2020

    Kidney Function Affection Upon Exposure to Radiocontrast, Diabetes, Microalbuminuria Trial in Fayoum (Linagliptin Oral Tablet)

    Completed
    • Kidney Function Affection Upon Exposure to Radiocontrast
    • +2 more
    • Linagliptin Oral Tablet
    • Fayoum, Egypt
    • +1 more
    Sep 12, 2020

    Type 2 Diabetes Trial in Hellerup (LY2403021, LY2403021 , Standardised liquid meal)

    Completed
    • Type 2 Diabetes
    • Hellerup, Denmark
      Center for Diabetes Research, Gentofte Hospital, Copenhagen Univ
    Apr 6, 2020

    Prediabetic State, Insulin Resistance Trial in León (Linagliptin + metformin, Metformin)

    Unknown status
    • Prediabetic State
    • Insulin Resistance
    • León, Guanauato, Mexico
      Universidad de Guanajuato
    Oct 22, 2019

    Diabetes, Type 2 Trial in China (, linagliptin, background therapy)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • placebo
    • +2 more
    • Beijing, China
    • +24 more
    Mar 24, 2020

    Type 2 Diabetes Trial in China (TQ-F3083 capsule 10 mg, TQ-F3083 capsule 20 mg, TQ-F3083 blank analog capsule)

    Unknown status
    • Type 2 Diabetes Mellitus
    • TQ-F3083 capsule 10 mg
    • +4 more
    • Chongqing, Chongqing, China
    • +8 more
    Mar 11, 2020

    Healthy Volunteers Trial in Seoul (GC2129A(Period 1), Linaglptin 5mg and Metformin Hydrocholoride 1000mg(Period 1),

    Recruiting
    • Healthy Volunteers
    • GC2129A(Period 1)
    • +3 more
    • Seoul, Korea, Republic of
      H Plus YangJi Hospital
    Jan 19, 2023

    Prediabetic State, Impaired Glucose Tolerance, Insulin Resistance Trial in León (Linagliptin / Metformin Oral Tablet, Metformin)

    Completed
    • Prediabetic State
    • +2 more
    • León, Guanajuato, Mexico
      Universidad de Guanajuato
    Sep 11, 2019

    Replication of the CARMELINA Diabetes Trial in Healthcare Claims

    Unknown status
    • Diabetes
    • Boston, Massachusetts
      Brigham & Women's Hospital
    Jan 28, 2020

    Diabetes, Type 2 Trial in Seoul (administration of UI068, administration of UIC202205, UIC202206)

    Completed
    • Diabetes Mellitus, Type 2
    • administration of UI068
    • administration of UIC202205, UIC202206
    • Seoul, Gwanak-gu, Korea, Republic of
      H plus Yangji Hospital
    Nov 15, 2023

    Healthy Volunteers Trial in Seoul (GC2129A(Period 1), Linaglptin 5mg and Metformin Hydrocholoride 1000mg(Period 1),

    Recruiting
    • Healthy Volunteers
    • GC2129A(Period 1)
    • +3 more
    • Seoul, Korea, Republic of
      H Plus YangJi Hospital
    Feb 6, 2023

    Prediabetic State, Insulin Resistance Trial in León (Linagliptin + metformin and Empagliflozin + metformin, Metformin)

    Unknown status
    • Prediabetic State
    • Insulin Resistance
    • Linagliptin + metformin and Empagliflozin + metformin
    • Metformin
    • León, Guanajuato, Mexico
      Universidad de Guanajuato
    Oct 17, 2019

    Type2 Diabetes, Albuminuria, Renal Insufficiency Trial in Seoul (Evogliptin, Linagliptin)

    Completed
    • Type2 Diabetes Mellitus
    • +2 more
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Sep 19, 2019

    ive Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

    Active, not recruiting
    • Diabetes
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Mar 3, 2023

    Linagliptin in Post-renal Transplantation

    Completed
    • Transplanted Kidney Complication
    • (no location specified)
    May 30, 2019

    Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma Trial in Worldwide (5-Fluorouracil

    Recruiting
    • Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
    • 5-Fluorouracil (5-FU)
    • +11 more
    • Scottsdale, Arizona
    • +41 more
    Jan 19, 2023

    Prediabetic State, Insulin Resistance Trial in León (Linagliptin + metformin, Metformin)

    Completed
    • Prediabetic State
    • Insulin Resistance
    • León, Guanajuato, Mexico
      Universidad de Guanajuato
    Jul 5, 2019